Microbiota, oral microbiome, and pancreatic cancer

Cancer Journal (United States)

Volumn 20, Issue 3, 2014, Pages 203-206

  Michaud, Dominique S ^a,b   Izard, Jacques ^c,d  

^a BROWN UNIVERSITY   (United States)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

^c FORSYTH INSTITUTE   (United States)

^d HARVARD SCHOOL OF DENTAL MEDICINE   (United States)

Author keywords

digestive tract; inflammation; pancreas; Periodontitis

Indexed keywords

ALPHA TOCOPHEROL; ANTIBODY; BETA CAROTENE; NITROSAMINE; TOBACCO SMOKE; TOLL LIKE RECEPTOR 4;

ACUTE PANCREATITIS; BACTERIAL TRANSLOCATION; BLOOD GROUP ABO SYSTEM; CANCER PREVENTION; CANCER RISK; CANCER SUSCEPTIBILITY; CARCINOGENESIS; CHRONIC PANCREATITIS; DIGESTIVE SYSTEM INFLAMMATION; EPIDEMIOLOGICAL DATA; GENE LOCUS; GENETIC SUSCEPTIBILITY; HELICOBACTER PYLORI; HUMAN; IMMUNE RESPONSE; LIFESTYLE MODIFICATION; MICROFLORA; MOUTH FLORA; NEISSERIA ELONGATA; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; PANCREAS ABSCESS; PANCREAS CANCER; PERIODONTAL DISEASE; PERIODONTITIS; PORPHYROMONAS GINGIVALIS; PRIORITY JOURNAL; REVIEW; STOMACH CANCER; STREPTOCOCCUS MITIS; IMMUNOLOGY; INFLAMMATION; MICROBIOLOGY; MOUTH; PANCREAS TUMOR; PATHOLOGY; RISK FACTOR;

HUMANS; INFLAMMATION; MICROBIOTA; MOUTH; PANCREATIC NEOPLASMS; RISK FACTORS;

EID: 84901493849     PISSN: 15289117     EISSN: 1540336X     Source Type: Journal    
DOI: 10.1097/PPO.0000000000000046     Document Type: Review

References (59)

1. Siegel R, Ma J, Zou Z, et al. Cancer statistics, 2014. CA Cancer J Clin. 2014;64:9-29. doi: 10.3322/caac.21208.
2. Shin EJ, Canto MI. Pancreatic cancer screening. Gastroenterol Clin North Am. 2012;41:143-157.
3. Harsha HC, Kandasamy K, Ranganathan P, et al. A compendium of potential biomarkers of pancreatic cancer. PLoS Med. 2009;6:e1000046.
4. Faca VM, Song KS,Wang H, et al. A mouse to human search for plasma proteome changes associated with pancreatic tumor development. PLoS Med. 2008;5:e123.
5. Yachida S, Jones S, Bozic I, et al. Distant metastasis occurs late during the genetic evolution of pancreatic cancer. Nature 2010;467:1114-1117.
6. Greer JB, Whitcomb DC. Inflammation and pancreatic cancer: an evidence-based review. Curr Opin Pharmacol. 2009;9:411-418.
7. IARC. A Review of Human Carcinogens. B. Biological Agents. Geneva, Switzerland: WHO Press, 2012.
8. Correa P. Gastric cancer: overview. Gastroenterol Clin North Am. 2013;42: 211-217.
9. Salama NR, Hartung ML, Muller A. Life in the human stomach: persistence strategies of the bacterial pathogen Helicobacter pylori. Nat Rev Microbiol. 2013;11:385-399.
10. Dorer MS, Talarico S, Salama NR. Helicobacter pylori's unconventional role in health and disease. PLoS Pathog. 2009;5:e1000544.
11. Correa P, Fox J, Fontham E, et al. Helicobacter pylori and gastric carcinoma. Serum antibody prevalence in populations with contrasting cancer risks. Cancer 1990;66:2569-2574.
12. Fukase K, Kato M, Kikuchi S, et al. Effect of eradication of Helicobacter pylori on incidence of metachronous gastric carcinoma after endoscopic resection of early gastric cancer: an open-label, randomised controlled trial. Lancet. 2008;372:392-397.
13. Cho SJ, Choi IJ, Kook MC, et al. Randomised clinical trial: the effects of Helicobacter pylori eradication on glandular atrophy and intestinal metaplasia after subtotal gastrectomy for gastric cancer. Aliment Pharmacol Ther. 2013;38:477-489.
14. Bao Y, Spiegelman D, Li R, et al. History of peptic ulcer disease and pancreatic cancer risk in men. Gastroenterology 2010;138:541-549.
15. Raderer M, Wrba F, Kornek G, et al. Association between Helicobacter pylori infection and pancreatic cancer. Oncology. 1998;55:16-19. (Pubitemid 128707618)
16. Stolzenberg-Solomon RZ, Blaser MJ, Limburg PJ, et al. Helicobacter pylori seropositivity as a risk factor for pancreatic cancer. J Natl Cancer Inst. 2001;93:937-941. (Pubitemid 32624651)
17. de Martel C, Llosa AE, Friedman GD, et al. Helicobacter pylori infection and development of pancreatic cancer. Cancer Epidemiol Biomarkers Prev. 2008;17:1188-1194.
18. Lindkvist B, Johansen D, Borgstrom A, et al. A prospective study of Helicobacter pylori in relation to the risk for pancreatic cancer. BMC Cancer 2008;8:321.
19. Risch HA, Yu H, Lu L, et al. ABO blood group, Helicobacter pylori seropositivity, and risk of pancreatic cancer: a case-control study. J Natl Cancer Inst. 2010;102:502-505.
20. Yu G, Murphy G, Michel A, et al. Seropositivity to Helicobacter pylori and risk of pancreatic cancer. Cancer Epidemiol Biomarkers Prev. 2013;22: 2416-2419.
21. Otomo-Corgel J, Pucher JJ, Rethman MP, et al. State of the science: chronic periodontitis and systemic health. J Evid Based Dent Pract. 2012;12:20-28.
22. Meyer MS, Joshipura K, Giovannucci E, et al. A review of the relationship between tooth loss, periodontal disease, and cancer. Cancer Causes Control. 2008;19:895-907.
23. Ansai T, Takata Y, Yoshida A, et al. Association between tooth loss and orodigestive cancer mortality in an 80-year-old community-dwelling Japanese population: a 12-year prospective study. BMC Public Health. 2013;13:814.
24. Tribble GD, Kerr JE, Wang BY. Genetic diversity in the oral pathogen Porphyromonas gingivalis: molecular mechanisms and biological consequences. Future Microbiol. 2013;8:607-620.
25. Papapanou PN. Periodontal diseases: epidemiology. Ann Periodontol. 1996;1:1-36.
26. Socransky SS, Haffajee AD. Evidence of bacterial etiology: a historical perspective. Periodontology 2000. 1994;5:7-25.
27. Hujoel PP, Drangsholt M, Spiekerman C, et al. An exploration of the periodontitis-cancer association. Ann Epidemiol. 2003;13:312-316. (Pubitemid 36765393)
28. Michaud DS, Joshipura K, Giovannucci E, et al. A prospective study of periodontal disease and pancreatic cancer in US male health professionals. J Natl Cancer Inst. 2007;99:171-175.
29. Ahn J, Segers S, Hayes RB. Periodontal disease, Porphyromonas gingivalis serum antibody levels and orodigestive cancer mortality. Carcinogenesis 2012;33:1055-1058.
30. Joshipura KJ, Douglass CW, Garcia RI, et al. Validity of a self-reported periodontal disease measure. J Public Health Dent. 1996;56:205-212. (Pubitemid 126700909)
31. Michaud DS, Izard J, Wilhelm-Benartzi CS, et al. Plasma antibodies to oral bacteria and risk of pancreatic cancer in a large European prospective cohort study. Gut. 2013;62:1764-1770.
32. Widdison AL. Pathogenesis of pancreatic infection. Ann R Coll Surg Engl. 1996;78:350-353. (Pubitemid 26241657)
33. Schmid SW, Uhl W, Friess H, et al. The role of infection in acute pancreatitis. Gut. 1999;45:311-316. (Pubitemid 29333786)
34. Swidsinski A, Schlien P, Pernthaler A, et al. Bacterial biofilm within diseased pancreatic and biliary tracts. Gut. 2005;54:388-395. (Pubitemid 40299096)
35. Brook I, Frazier EH. Microbiological analysis of pancreatic abscess. Clin Infect Dis. 1996;22:384-385. (Pubitemid 26056182)
36. Hill MC, Dach JL, Barkin J, et al. The role of percutaneous aspiration in the diagnosis of pancreatic abscess. AJR Am J Roentgenol. 1983;141: 1035-1038.
37. Tsui NC, Zhao E, Li Z, et al. Microbiological findings in secondary infection of severe acute pancreatitis: a retrospective clinical study. Pancreas 2009;38:499-502.
38. Dewhirst FE, Chen T, Izard J, et al. The human oral microbiome. J Bacteriol. 2010;192:5002-5017.
39. Noor MT, Radhakrishna Y, Kochhar R, et al. Bacteriology of infection in severe acute pancreatitis. JOP. 2011;12:19-25.
40. Widdison AL, Karanjia ND, Reber HA. Routes of spread of pathogens into the pancreas in a feline model of acute pancreatitis. Gut. 1994;35: 1306-1310. (Pubitemid 24277350)
41. Fritz S, Hackert T, Hartwig W, et al. Bacterial translocation and infected pancreatic necrosis in acute necrotizing pancreatitis derives from small bowel rather than from colon. Am J Surg. 2010;200:111-117.
42. Kinane DF, Riggio MP, Walker KF, et al. Bacteraemia following periodontal procedures. J Clin Periodontol. 2005;32:708-713. (Pubitemid 40923043)
43. Sconyers JR, Crawford JJ, Moriarty JD. Relationship of bacteremia to toothbrushing in patients with periodontitis. J Am Dent Assoc. 1973;87: 616-622.
44. Hayashi C, Gudino CV, Gibson FC3rd, et al. Review: Pathogen-induced inflammation at sites distant from oral infection: bacterial persistence and induction of cell-specific innate immune inflammatory pathways. Mol Oral Microbiol. 2010;25:305-316.
45. Singh A, Wyant T, Anaya-Bergman C, et al. The capsule of porphyromonas gingivalis leads to a reduction in the host inflammatory response, evasion of phagocytosis, and increase in virulence. Infect Immun. 2011;79:4533-4542.
46. Taxman DJ, Swanson KV, Broglie PM, et al. Porphyromonas gingivalis mediates inflammasome repression in polymicrobial cultures through a novel mechanism involving reduced endocytosis. J Biol Chem. 2012;287: 32791-32799.
47. Palm E, Khalaf H, Bengtsson T. Porphyromonas gingivalis downregulates the immune response of fibroblasts. BMC Microbiol. 2013;13:155.
48. Hayashi C, Papadopoulos G, Gudino CV, et al. Protective role for TLR4 signaling in atherosclerosis progression as revealed by infection with a common oral pathogen. J Immunol. 2012;189:3681-3688.
49. Ochi A, Nguyen AH, Bedrosian AS, et al. MyD88 inhibition amplifies dendritic cell capacity to promote pancreatic carcinogenesis via Th2 cells. J Exp Med. 2012;209:1671-1687.
50. Zhang JJ, Wu HS, Wang L, et al. Expression and significance of TLR4 and HIF-1alpha in pancreatic ductal adenocarcinoma. World J Gastroenterol. 2010;16:2881-2888.
51. Risch HA. Etiology of pancreatic cancer, with a hypothesis concerning the role of N-nitroso compounds and excess gastric acidity. J Natl Cancer Inst. 2003;95:948-960. (Pubitemid 36896712)
52. Nair J, Ohshima H, Nair UJ, et al. Endogenous formation of nitrosamines and oxidative DNA-damaging agents in tobacco users. Crit Rev Toxicol. 1996;26:149-161. (Pubitemid 26111895)
53. Shapiro KB, Hotchkiss JH, Roe DA. Quantitative relationship between oral nitrate-reducing activity and the endogenous formation of N-nitrosoamino acids in humans. Food Chem Toxicol. 1991;29:751-755.
54. Joshipura KJ, Wand HC, Merchant AT, et al. Periodontal disease and biomarkers related to cardiovascular disease. J Dent Res. 2004;83: 151-155. (Pubitemid 41713800)
55. Farrell JJ, Zhang L, Zhou H, et al. Variations of oral microbiota are associated with pancreatic diseases including pancreatic cancer. Gut. 2012;61: 582-588.
56. Amundadottir L, Kraft P, Stolzenberg-Solomon RZ, et al. Genome-wide association study identifies variants in the ABO locus associated with susceptibility to pancreatic cancer. Nat Genet. 2009;41:986-990.
57. Wei P, Tang H, Li D. Insights into pancreatic cancer etiology from pathway analysis of genome-wide association study data. PLoS One 2012;7:e46887.
58. Wang DS, Chen DL, Ren C, et al. ABO blood group, hepatitis B viral infection and risk of pancreatic cancer. Int J Cancer 2012;131:461-468.
59. Pare G, Chasman DI, Kellogg M, et al. Novel association of ABO histoblood group antigen with soluble ICAM-1: results of a genome-wide association study of 6,578 women. PLoS Genet. 2008;4:e1000118.